The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias (Q40526847)

21 September 2017

1 reference

title

The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias (English)

1 reference

21 September 2017

0 references

Cunha BA

1

1 reference

21 September 2017

1 May 1995

1 reference

Medical Clinics of North America

21 September 2017

1 reference

21 September 2017

79

1 reference

21 September 2017

3

1 reference

21 September 2017

581-597

1 reference

A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Principles of tissue penetration of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Outbreak of Chlamydia pneumoniae infection in former injection-drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Endobronchial pH. Relevance of aminoglycoside activity in gram-negative bacillary pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

The stomach is not a source for colonization of the upper respiratory tract and pneumonia in ICU patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Atypical pneumonias. Clinical diagnosis and empirical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Pneumonias acquired from others. 1. History, examination, laboratory findings

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

The atypical pneumonias: a diagnostic and therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Empiric therapy for pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Aetiology and treatment of community-acquired pneumonia in adults: an historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Treatment recommendations for respiratory tract infections associated with aging

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Oral empirical treatment of pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

The Safety and Efficacy of Clarithromycin in Patients with Legionella Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Atypical pneumonias. Clinical and extrapulmonary features of Chlamydia, Mycoplasma, and Legionella infections

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Antibiotic usage in community-acquired pneumonia: Results of a survey in 288 departments of internal medicine in German hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Antibacterial Therapy for Lower Respiratory Tract Infections in Adults: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Systemic antimicrobial therapy of nosocomial pneumonia: monotherapy versus combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Rational approach to the antibiotic treatment of pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Severe community-acquired pneumonia. Etiology, prognosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Penetration of antibiotics into respiratory secretions.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Failure of erythromycin in treatment of Legionella micdadei pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Principles of antibiotic tissue penetration and guidelines for pharmacokinetic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Tissue levels of doxycycline in the human lung and pleura

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930058-X

7 January 2021

10.1016/S0025-7125(16)30058-X

Identifiers

DOI

0 references

PubMed ID

7752730

1 reference

PubMed ID

7752730